Anticipation in familial leukemia

Area of Science:

• Genetics
• Oncology
• Molecular Biology

Background:

• Anticipation, characterized by earlier disease onset or increased severity across generations, is typically observed in neurodegenerative disorders.
• It is often linked to the expansion of trinucleotide repeats within genes.
• The phenomenon of anticipation has not been extensively studied in hematologic malignancies.

Purpose of the Study:

• To investigate the presence and extent of anticipation in familial cases of leukemia.
• To explore the potential role of dynamic DNA mutations in inherited blood cancers.

Main Methods:

• Analysis of age at onset across three generations in families with autosomal dominant acute myelogenous leukemia (AML) and chronic lymphocytic leukemia (CLL).
• Comparison of age at onset between parents and children in familial leukemia pedigrees.
• Statistical analysis to determine the significance of observed age declines.

Main Results:

• A significant decrease in age at onset was observed across generations in familial AML (mean decline of 28 years) and CLL (mean decline of 21 years).
• Nineteen out of 21 parent-child AML pairs and eight out of nine parent-child CLL pairs showed anticipation.
• Findings were consistent across various types of leukemia and lymphoma pedigrees, and sampling bias was deemed unlikely.

Conclusions:

• Anticipation is a feature of inherited leukemia, supporting the hypothesis of dynamic mutations in unstable DNA repeats.
• This mechanism may contribute to the development of familial hematopoietic malignancies.
• Potential candidate genes for familial leukemia with anticipation include loci on chromosomes 21q22.1-22.2, 11q23.3 (CBL2), and 16q22 (CBFB).